Published in J Chem Neuroanat on June 01, 2001
Effects of a formal exercise program on Parkinson's disease: a pilot study using a delayed start design. Parkinsonism Relat Disord (2013) 2.05
Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates. Nat Rev Neurosci (2011) 1.45
Activation of CNTF/CNTFRα signaling pathway by hRheb(S16H) transduction of dopaminergic neurons in vivo. PLoS One (2015) 1.38
Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol (2008) 1.38
Does vigorous exercise have a neuroprotective effect in Parkinson disease? Neurology (2011) 1.28
Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration. Eur J Neurosci (2011) 1.24
Targets for neuroprotection in Parkinson's disease. Biochim Biophys Acta (2008) 1.08
A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease. Biochim Biophys Acta (2009) 1.02
Neuroregeneration in neurodegenerative disorders. BMC Neurol (2011) 0.98
Mood, memory and movement: an age-related neurodegenerative complex? Curr Aging Sci (2008) 0.93
Pathogenesis-targeted, disease-modifying therapies in Parkinson disease. Neurotherapeutics (2014) 0.92
Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease. Neuroscience (2011) 0.90
Identification of novel GDNF isoforms and cis-antisense GDNFOS gene and their regulation in human middle temporal gyrus of Alzheimer disease. J Biol Chem (2011) 0.88
GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease. Front Neuroanat (2015) 0.87
Immune privilege as an intrinsic CNS property: astrocytes protect the CNS against T-cell-mediated neuroinflammation. Mediators Inflamm (2013) 0.86
Naringin: a protector of the nigrostriatal dopaminergic projection. Exp Neurobiol (2014) 0.86
Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats. Neuroscience (2009) 0.83
Neuroprotective changes in degeneration-related gene expression in the substantia nigra following acupuncture in an MPTP mouse model of Parkinsonism: Microarray analysis. Genet Mol Biol (2014) 0.81
Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous mice. Brain Pathol (2010) 0.81
Glial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNF. Pharmacol Biochem Behav (2013) 0.80
The nigrostriatal dopamine system of aging GFRalpha-1 heterozygous mice: neurochemistry, morphology and behavior. Eur J Neurosci (2008) 0.80
Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives. Int J Mol Sci (2016) 0.80
Dynamic High-Cadence Cycling Improves Motor Symptoms in Parkinson's Disease. Front Neurol (2015) 0.79
Effects of aging on glutamate neurotransmission in the substantia nigra of Gdnf heterozygous mice. Neurobiol Aging (2014) 0.78
Targeting histone deacetylases: a novel approach in Parkinson's disease. Parkinsons Dis (2015) 0.78
Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications. Int J Neuropsychopharmacol (2016) 0.78
Quinolinic acid lesions of the caudate putamen in the rat lead to a local increase of ciliary neurotrophic factor. J Anat (2004) 0.77
Promoting exercise in Parkinson's disease through community-based participatory research. Neurodegener Dis Manag (2011) 0.77
IGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases. Exp Brain Res (2016) 0.77
Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications. Pharmaceuticals (Basel) (2012) 0.77
''70th Birthday Professor Riederer'' induction of glial cell line-derived and brain-derived neurotrophic factors by rasagiline and (-)deprenyl: a way to a disease-modifying therapy? J Neural Transm (Vienna) (2012) 0.76
Glial Cell Line-Derived Neurotrophic Factor Gene Delivery in Parkinson's Disease: A Delicate Balance between Neuroprotection, Trophic Effects, and Unwanted Compensatory Mechanisms. Front Neuroanat (2017) 0.75
Roles of Rheb(S16H) in substantia nigra pars compacta dopaminergic neurons in vivo. Biomed Rep (2014) 0.75
Repetitive transcranial magnetic stimulation (rTMS) improves behavioral and biochemical deficits in levodopa-induced dyskinetic rats model. Oncotarget (2016) 0.75
Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support. Neurochem Int (2017) 0.75
Inhibition of microglial activation and induction of neurotrophic factors by flavonoids: a potential therapeutic strategy against Parkinson's disease. Neural Regen Res (2015) 0.75
Neurotrophic function of phytochemicals for neuroprotection in aging and neurodegenerative disorders: modulation of intracellular signaling and gene expression. J Neural Transm (Vienna) (2017) 0.75
Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy. Neural Regen Res (2017) 0.75
Isolation of the human insulin-like growth factor I gene using a single synthetic DNA probe. EMBO J (1984) 3.74
High-density microarray-mediated gene expression profiling of Escherichia coli. J Bacteriol (2001) 3.45
Locus-specific variation in phosphorylation state of RNA polymerase II in vivo: correlations with gene activity and transcript processing. Genes Dev (1993) 2.82
The C-terminal repeat domain of RNA polymerase II largest subunit is essential in vivo but is not required for accurate transcription initiation in vitro. Proc Natl Acad Sci U S A (1988) 2.39
A study of factors influencing the rural location of health professionals. J Med Educ (1977) 2.33
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem (1998) 2.32
A gene expression profile of Alzheimer's disease. DNA Cell Biol (2001) 2.16
p53 regulates a G2 checkpoint through cyclin B1. Proc Natl Acad Sci U S A (1999) 2.16
The yeast carboxyl-terminal repeat domain kinase CTDK-I is a divergent cyclin-cyclin-dependent kinase complex. Mol Cell Biol (1995) 2.14
Observations on the effect of movement on bone ingrowth into porous-surfaced implants. Clin Orthop Relat Res (1986) 2.08
Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. Cancer Lett (2000) 2.02
Anatomical collateral ligament reconstruction in the hand using intraosseous suture anchors and a free tendon graft. J Hand Surg Eur Vol (2012) 1.98
Japanese encephalitis in north Queensland, Australia, 1998. Med J Aust (1999) 1.96
RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins. Mol Cell Biol (1999) 1.86
Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana. Nature (2000) 1.85
Global impact of sdiA amplification revealed by comprehensive gene expression profiling of Escherichia coli. J Bacteriol (2001) 1.78
Global expression profiling of yeast treated with an inhibitor of amino acid biosynthesis, sulfometuron methyl. Physiol Genomics (2000) 1.67
Surgical treatment for pulmonary aspergilloma: a 28 year experience. Thorax (1997) 1.63
An analysis using DNA microarray of the time course of gene expression during syncytialization of a human placental cell line (BeWo). Placenta (2004) 1.62
Effect of remifentanil on oculocardiac reflex in paediatric strabismus surgery. Acta Anaesthesiol Scand (2008) 1.61
Pharmacological drug treatment of Alzheimer disease: the cholinergic hypothesis revisited. J Neuropathol Exp Neurol (1998) 1.57
The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci (2000) 1.51
Reducing calcium overload in the ischemic brain. N Engl J Med (1999) 1.50
Thyroxine suppressive therapy of benign solitary thyroid nodules: a prospective randomized study. World J Surg (1990) 1.49
Intestinal inflammation and impact on growth in children with cystic fibrosis. J Pediatr Gastroenterol Nutr (2015) 1.47
Oculomotor nerve cavernous angioma in a patient with Roberts syndrome. Surg Neurol (1993) 1.46
MR imaging-histopathologic correlation of radiofrequency thermal ablation lesion in a rabbit liver model: observation during acute and chronic stages. Korean J Radiol (2001) 1.43
eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration. Oncogene (2006) 1.41
Use of esophagectomy to treat recurrent hyperplastic tissue obstruction caused by multiple metallic stent insertion for corrosive stricture. Endoscopy (2000) 1.41
Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol (2001) 1.39
Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors. J Virol (2001) 1.39
The detection and treatment of early lung cancer. Ann Surg (1974) 1.39
Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics. Am J Respir Crit Care Med (2000) 1.32
The appearance of a second genotype of Japanese encephalitis virus in the Australasian region. Am J Trop Med Hyg (2001) 1.32
Differences in platelet enzyme activity between alcoholics and nonalcoholics. N Engl J Med (1988) 1.31
Microtubule stability in budding yeast: characterization and dosage suppression of a benomyl-dependent tubulin mutant. Mol Biol Cell (1995) 1.27
The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity. Proc Natl Acad Sci U S A (1999) 1.27
Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea. J Korean Med Sci (2001) 1.27
Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res (1991) 1.24
The NS1 protein of tick-borne encephalitis virus forms multimeric species upon secretion from the host cell. J Gen Virol (1994) 1.24
The visual variant of Alzheimer's disease: a clinicopathologic case study. Neurology (1993) 1.24
An inexpensive meter to measure differences in electrical resistance in the rat vagina during the ovarian cycle. J Appl Physiol (1985) (2001) 1.24
Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett (1998) 1.21
Diffuse hepatic hemangiomatosis in an adult. J Korean Med Sci (2000) 1.21
Neuronal apoptosis after CNS injury: the roles of glutamate and calcium. J Neurotrauma (2000) 1.21
Comparing MR imaging and CT in the staging of gastric carcinoma. AJR Am J Roentgenol (2000) 1.21
Risk of betel chewing for oesophageal cancer in Taiwan. Br J Cancer (2001) 1.20
Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. J Biomed Mater Res (1994) 1.19
SEPT5_v2 is a parkin-binding protein. Brain Res Mol Brain Res (2003) 1.17
A case of intramuscular sparganosis in the sartorius muscle. J Korean Med Sci (2001) 1.17
Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology (2001) 1.16
Chemoprotective properties of some pungent ingredients present in red pepper and ginger. Mutat Res (1998) 1.14
Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein. Exp Neurol (2005) 1.14
Patients with partial seizures: evaluation by MR, CT, and PET imaging. Radiology (1986) 1.12
Assaying CTD kinases in vitro and phosphorylation-modulated properties of RNA polymerase II in vivo. Methods (1997) 1.11
Toxicity of human adenovirus E4orf4 protein in Saccharomyces cerevisiae results from interactions with the Cdc55 regulatory B subunit of PP2A. Oncogene (2001) 1.10
Carcinoma of the head of the pancreas and periampullary region. Johns Hopkins Med J (1973) 1.10
Developmental and environmental regulation of two ribosomal protein genes in tobacco. Plant Mol Biol (1994) 1.09
In vitro and in vivo antibacterial activities of CFC-222, a novel broad spectrum fluoroquinolone. Drugs (1995) 1.09
Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism. J Neurol Neurosurg Psychiatry (1971) 1.09
Germline transformation of the sawfly, Athalia rosae (Hymenoptera: Symphyta), mediated by a piggyBac-derived vector. Insect Biochem Mol Biol (2003) 1.09
Phosphorylation dependence of the initiation of productive transcription of Balbiani ring 2 genes in living cells. Chromosoma (1996) 1.09
Immunocytochemical localization of Na+,K+-ATPase catalytic polypeptide in mouse choroid plexus. J Histochem Cytochem (1986) 1.09
Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Arthritis Res (2000) 1.08
Sodium-potassium-activated adenosine triphosphatase of Electrophorus electric organ. IV. Modification of responses to sodium and potassium by arsenite plus 2,3-dimercaptopropanol. J Biol Chem (1967) 1.07
Chondroid chordoma--a variant of chordoma. A morphologic and immunohistochemical study. Am J Clin Pathol (1994) 1.06
Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model. Cancer Gene Ther (2008) 1.06
Differences between lateral and mesial temporal metabolism interictally in epilepsy of mesial temporal origin. Neurology (1990) 1.06
Refractory giant cell arteritis with spinal cord infarction. Neurology (1997) 1.05
The EEG and prognosis in status epilepticus. Epilepsia (1999) 1.05
CT findings of extramedullary hematopoiesis in the thorax, liver and kidneys, in a patient with idiopathic myelofibrosis. J Korean Med Sci (2000) 1.05
Purification and analysis of infectious virions and native non-structural antigens from cells infected with tick-borne encephalitis virus. J Chromatogr (1990) 1.04
Permeability barrier requirements regulate epidermal beta-glucocerebrosidase. J Lipid Res (1994) 1.04
Local and distant histopathological effects of unilateral amyloid-beta 25-35 injections into the amygdala of young F344 rats. Neurobiol Aging (1997) 1.04
Biodegradation of 4-chlorophenol via a hydroquinone pathway by Arthrobacter ureafaciens CPR706. FEMS Microbiol Lett (1996) 1.04
Neurokinin-3 receptor distribution in rat and human brain: an immunohistochemical study. Neuroscience (1999) 1.03
AAC-11 overexpression induces invasion and protects cervical cancer cells from apoptosis. Lab Invest (2000) 1.03
The SH2 domain is required for stable phosphorylation of p56lck at tyrosine 505, the negative regulatory site. Mol Cell Biol (1993) 1.03
Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation. Blood Cancer J (2012) 1.02
Gallbladder wall thickening: MR imaging and pathologic correlation with emphasis on layered pattern. Eur Radiol (2004) 1.02
Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease. Ann Neurol (1999) 1.02
Estrogen receptor alpha genotype is associated with a reduced prevalence of radiographic hip osteoarthritis in elderly Caucasian women. Osteoarthritis Cartilage (2007) 1.02
Solitary necrotic nodules of the liver mimicking hepatic metastasis: report of two cases. Korean J Radiol (2001) 1.02
Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human cervical cancers. Gynecol Oncol (1998) 1.02
Septic arthritis versus transient synovitis at MR imaging: preliminary assessment with signal intensity alterations in bone marrow. Radiology (1999) 1.01
Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer's disease patient. J Mol Neurosci (1995) 1.01
Regulation of p53-mediated apoptosis and cell cycle arrest by Steel factor. Mol Cell Biol (1995) 1.01
Acute appendicitis in the elderly. Surg Gynecol Obstet (1985) 1.01
What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case-control study. Int J Gynecol Cancer (2006) 1.01
Acellular matrix: a biomaterials approach for coronary artery bypass and heart valve replacement. Ann Thorac Surg (1995) 1.00
Promoter elements controlling developmental and environmental regulation of a tobacco ribosomal protein gene L34. Plant Mol Biol (1996) 1.00
Reduction of calcineurin enzymatic activity in Alzheimer's disease: correlation with neuropathologic changes. J Neuropathol Exp Neurol (1996) 1.00
Imaging of intrahepatic and hilar cholangiocarcinoma. Abdom Imaging (2004) 1.00
The effect of gynaecological laparoscopic surgery on cerebral oxygenation. J Int Med Res (2006) 1.00
Cutaneous exposure to warfarin-like anticoagulant causing an intracerebral hemorrhage: a case report. J Toxicol Clin Toxicol (1994) 0.99
Evaluation of L-dopa therapy in Parkinson's disease. N Y State J Med (1970) 0.99
Small gastrointestinal stromal tumours with focal areas of low attenuation on CT: pathological correlation. Clin Radiol (2005) 0.99
Expression of hMSH2 and hMLH1 in colorectal carcinomas with microsatellite instability. Pathol Res Pract (1998) 0.99
Effects of ice on nerve conduction velocity. Physiotherapy (1978) 0.99
Rosai-Dorfman disease mimicking parasagittal meningioma: case presentation and review of literature. Surg Neurol (2000) 0.98